Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Acebutolol impurity 7 is a secondary compound generated during the synthesis of Acebutolol, a selective beta-1 adrenergic receptor blocker. This reagent is primarily utilized in drug development and quality control to ensure the purity and safety of pharmaceutical formulations. Its characterization and analysis are essential for compliance with regulatory standards in chemical research and formulation studies. -
Drug Impurity
Dexmedetomidine impurity 2 is a chemical impurity related to Dexmedetomidine, a selective alpha-2 adrenergic receptor agonist. This impurity is significant in assessing the purity and quality of Dexmedetomidine formulations. It is utilized primarily in analytical chemistry and pharmaceutical development, particularly for the evaluation of drug substances and ensuring compliance with regulatory standards. -
Drug Impurity
Pramipexole impurity 1 (2-N-Propyl pramipexole) is a chemical impurity associated with the drug Pramipexole, which targets dopamine receptors. This impurity is essential for quality control and validation studies in pharmaceutical research, ensuring the purity and safety of drug formulations. It serves as a reference compound in analytical chemistry and can facilitate the investigation of drug metabolism and pharmacokinetics. -
Drug Impurity
Ropinirole impurity 2 is a chemical impurity associated with the synthesis of Ropinirole, a dopamine receptor agonist. This compound can be utilized for analytical purposes in the assessment of drug purity and quality control in pharmaceutical research. Its presence is significant for the evaluation of Ropinirole formulations and may impact the overall efficacy and safety profile of the drug. -
Drug Impurity
Alfuzosin EP impurity 1 hydrochloride, also known as 2,3,4,5-Tetradehydro alfuzosin hydrochloride, is a recognized impurity of Alfuzosin hydrochloride. This compound is essential for evaluating the purity and stability of alfuzosin formulations in pharmaceutical development. Researchers may utilize this impurity in studies assessing drug quality, pharmacokinetics, and mechanism of action related to alpha-1 adrenergic receptor antagonism. -
H3 Agonist
Immepip dihydrobromide acts as a selective agonist for the H3 histamine receptor. It is known to attenuate cortical histamine release, thereby influencing neurotransmitter dynamics. This compound is applicable in the study of neurological disorders, providing insights into histaminergic system modulation and its potential therapeutic effects. -
Smoothened Agonist
SAG dihydrochloride is a potent Smoothened (Smo) receptor agonist, with an EC50 of 3 nM and a Kd of 59 nM. This compound effectively activates the Hedgehog signaling pathway, providing a robust mechanism to counteract the inhibitory effects of Cyclopamine. SAG dihydrochloride is valuable for research in developmental biology, cancer biology, and therapeutic strategies targeting Hedgehog-related pathways. -
Smoothened Antagonist
KAAD-Cyclopamine is an antagonist of the Smoothened receptor, a critical component of the Hedgehog signaling pathway. This compound effectively inhibits hedgehog signaling, thereby influencing cell proliferation and differentiation processes. It is widely used in research related to developmental biology, cancer, and regenerative medicine, facilitating the study of signaling cascades and their implications in various diseases. -
hSMOX Inhibitor
JNJ-1289 is a potent and selective inhibitor of human spermine oxidase (hSMOX), exhibiting a competitive and allosteric mechanism of action with an IC50 value of 50 nM. This compound is primarily utilized in research studies focused on polyamine catabolism, inflammation, and various cancer models, providing valuable insights into the role of hSMOX in these biological processes. -
Smo Probe
BODIPY-Cyclopamine is a fluorescent ligand targeting the Smoothened (SMO) receptor, crucial for Hedgehog signaling pathway regulation. Dysregulation of this pathway is linked to tumorigenesis, making BODIPY-Cyclopamine valuable for research related to cancer biology. Utilizing the NanoBRET (Nanofluorescein bioluminescence resonance energy transfer) technique, this compound facilitates the sensitive detection of energy transfer between SMO and the fluorescent probe, enabling high-throughput screening and kinetic studies. Additionally, investigating the binding dynamics of BODIPY-Cyclopamine can assist in the development of SMO-targeted therapeutics. -
Smo Receptors Antagonist
MRT-81 is a potent antagonist of smoothened (Smo) receptors in both human and rodent models, exhibiting an IC50 value of 41 nM in Shh-light2 cells. This compound effectively inhibits hedgehog signaling pathways, making it a valuable tool in cancer research. Its ability to modulate Smo activity facilitates investigations into Hedgehog pathway-related tumors and their therapeutic interventions. -
Smo Antagonist
IHR-1 is a cell membrane impermeable antagonist of Smoothened (Smo), a key component of the Hedgehog signaling pathway. This compound effectively inhibits Smo activity, making it a valuable tool for studying Hedgehog-related biological processes and disease states, such as cancer and developmental disorders. IHR-1's specificity for Smo allows for targeted research into the mechanistic roles of this pathway in various cellular contexts. -
Smo Inhibitor
MRT-83 hydrochloride is a potent Smoothened (Smo) receptor antagonist. By inhibiting the Hedgehog (Hh) signaling pathway and BODIPY-cyclopamine binding to human Smo, MRT-83 hydrochloride demonstrates significant biological activity. This compound is particularly relevant for research applications focused on cancer and associated signaling pathways. -
Smo Antagonist
MRT-10 is a smoothened (Smo) antagonist that effectively inhibits Smo activity with an IC50 of 0.65 μM in various Hedgehog (Hh) signaling assays. By binding to the Bodipycyclopamine-binding site on the Smo receptor, MRT-10 serves as a valuable tool for investigating the roles of Hedgehog signaling in cancer biology. Its application may extend to studies focused on tumor growth and progression influenced by aberrant Hedgehog pathway activation. -
Smoothened Inhibitor
Glasdegib maleate is a potent smoothened inhibitor that selectively targets the human Smoothened (SMO) protein. With an IC50 value of 4 nM, this orally bioavailable compound effectively modulates the Hedgehog signaling pathway, making it valuable for research in cancer biology and developmental processes. Glasdegib maleate is primarily used in studies investigating tumor growth and metastasis driven by aberrant Hedgehog signaling. -
Smo Inhibitor
Glasdegib hydrochloride is a potent smoothened (SMO) inhibitor, primarily targeting the Hedgehog signaling pathway. It exhibits high affinity for human SMO, with an IC50 of 4 nM, making it an effective tool for research in cancer biology and developmental processes. This compound is valuable for studies investigating the role of SMO in tumorigenesis and therapeutic resistance in various malignancies. -
SMO Inhibitor
AZD7254 is an orally active Smoothened (SMO) inhibitor with a reported EC50 of 1.0 nM against Sonic Hedgehog (Shh) protein. This compound effectively modulates hedgehog signaling pathways, making it a valuable tool for investigating the role of SMO in various cancers and developmental disorders. Its potent inhibition of SMO activity supports research applications in targeted therapies and pathway analysis. -
Smo Antagonist
MRT-14 is a potent Smoothened (Smo) antagonist, specifically targeting the Hedgehog (Hh) signaling pathway. By inhibiting Smo, MRT-14 disrupts the signal transduction linked to Hh morphogens. This compound demonstrates potential for research applications in various cancers associated with dysregulated Hh signaling. -
Smo Agonist
(Rac)-SAG is a potent agonist of the Smoothened (Smo) receptor, exhibiting an EC50 of 3 nM and a Kd of 59 nM. This compound activates the Hedgehog signaling pathway, making it an invaluable tool in studies focused on Smo-mediated processes. Additionally, (Rac)-SAG can counteract the inhibition of Smo by Cyclopamine, facilitating research into signaling and developmental biology. -
SMO Inhibitor
SMO-IN-1 is an orally active Smoothened (SMO) inhibitor that demonstrates an EC50 of 89 nM for sonic hedgehog (Shh) protein. This compound is effective in disrupting the hedgehog signaling pathway, making it a valuable tool in cancer research and developmental biology studies. It may be particularly relevant for investigating tumors associated with aberrant hedgehog signaling. -
Smoothened Antagonist
SMO-IN-4 is a potent oral antagonist of the Smoothened (SMO) protein, displaying an IC50 of 24 nM. This compound demonstrates significant antitumor activity and is utilized in research focused on hedgehog signaling pathways and cancer therapy. SMO-IN-4 serves as a valuable tool for investigating SMO-related mechanisms in various malignancies. -
Smo Antagonist
PF-5274857 hydrochloride is a potent, selective antagonist of Smoothened (Smo) with an IC50 of 5.8 nM and a Ki of 4.6 nM. Its oral bioavailability and ability to penetrate the blood-brain barrier enhance its utility in research on tumors, particularly brain tumors and brain metastases associated with an activated Hedgehog (Hh) signaling pathway. This compound is valuable for studies aimed at understanding Smo-mediated tumorigenesis and developing targeted therapeutics. -
Smo Activator
7-keto-25-Hydroxycholesterol is an oxysterol that acts as an activator of Smoothened (Smo). This compound interacts specifically with the extracellular cysteine-rich domain (CRD) of Smo, facilitating its activation. Research applications include studies on hedgehog signaling pathways and the exploration of Smo’s role in developmental biology and cancer. -
Smo Inhibitor
Saridegib hydrochloride is a selective inhibitor of Smoothened (Smo), a critical component of the Hedgehog (Hh) signaling pathway. By targeting Smo, this compound effectively disrupts Hh-mediated signaling, which is implicated in various developmental processes and diseases, including cancer. It is utilized in research to explore the role of the Hh pathway in tumorigenesis and as a potential therapeutic approach in Smo-dependent malignancies. -
ARα2c Inhibitor
BAY-2925976 is an α2C adrenergic receptor (ARα2C) inhibitor that selectively blocks receptor activity. This compound is primarily utilized in research related to obstructive sleep apnea (OSA), providing insights into its underlying mechanisms and potential therapeutic approaches. BAY-2925976 aids in elucidating the role of ARα2C in respiratory regulation and sleep disorders. -
β-AR Antagonist
Lubabegron fumarate is a selectiveβ-adrenergic receptor (β-AR) modulator, exhibiting antagonistic properties at both β1 and β2 receptor subtypes while acting as an agonist at the β3 subtype in bovine species. This compound effectively reduces ammonia (NH3) gas emissions from livestock and their waste, making it a valuable tool for improving environmental sustainability in agricultural practices. Lubabegron fumarate is primarily used in research applications focused on animal health and emissions management. -
Drug Derivative
SKF 83692 is a potent derivative that primarily targets dopamine receptors, specifically D1-like receptors. This compound exhibits notable biological activity in modulating dopaminergic signaling, making it valuable for research in neuropharmacology and the study of dopamine-related disorders. SKF 83692 serves as an important tool for investigating receptor pharmacology and the potential therapeutic effects of dopamine modulation in various neurological conditions. -
Propranolol Analogue
KP-19 is a Propranolol analogue that targets β-adrenergic receptors, influencing cardiac function and stress response. This compound exhibits potential biological activity in modulating cardiovascular mechanisms and offers insights into the treatment of cardiovascular diseases. Its application in research may contribute to understanding therapeutic strategies for managing heart-related conditions. -
Benzofuran
5-EAPB hydrochloride is a benzofuran derivative that acts primarily as a serotonin and dopamine receptor modulator. This compound is known for its psychoactive properties and has been used in neurological research to explore the mechanisms of mood regulation and cognitive function. Its ability to enhance serotonergic transmission makes it a valuable tool for studying various neuropharmacological applications. -
Intermediate
4-Propionamidophenol is an important intermediate in the synthesis of alkanolamine derivatives, primarily targeting β-adrenergic receptors. This compound exhibits significant β-adrenergic blocking activity, making it useful for research into cardiovascular conditions, including heart disease and hypertension. Its utility in synthesizing related compounds enhances its potential for various pharmacological studies. -
Phytocannabinoid
Δ9-Tetrahydrocannabivarinic acid (THCVA) is a phytocannabinoid that acts primarily on cannabinoid receptors, influencing various physiological processes. It exhibits potential anti-inflammatory properties and may play a role in modulating appetite and pain perception. THCVA is of interest in research relating to the therapeutic applications of cannabinoids in treating metabolic disorders and neurological conditions. -
Semaglutide Prodrug
Semaglutide Main Chain (9-37) serves as a peptide starting material for the synthesis of the semaglutide prodrug. This compound is integral in facilitating the development of semaglutide, which is a GLP-1 receptor agonist known for its role in enhancing glucose-dependent insulin secretion and reducing appetite. It is widely applicable in diabetes research and therapeutic development aimed at metabolic disorders. -
Somatostatin Analogue
DOTAMTATE is a somatostatin analogue that selectively targets somatostatin receptors. It exhibits significant potential for the imaging and treatment of somatostatin receptor-positive neuroendocrine tumors, making it a valuable tool for investigative research in oncology and radiopharmaceutical applications. The incorporation of 212Pb into DOTAMTATE enhances its therapeutic efficacy and suitability for targeted radionuclide therapy. -
Tetrahydrocannabinol Derivative
Δ9-THC-Ethyl is a derivative of Tetrahydrocannabinol (THC) featuring an ethyl chain modification. This compound primarily targets cannabinoid receptors and exhibits significant psychoactive properties. It is used in research to explore the pharmacological effects of cannabinoids, their therapeutic potential, and to study their role in various physiological processes. -
AEA Prodrug Analog
R-1 Methanandamide Phosphate is a water-soluble prodrug analog of arachidonylethanolamide (AEA), which acts primarily on cannabinoid receptors. This compound exhibits biological activity by enhancing the effects of endocannabinoids, providing insights into cannabinoid signaling pathways. It is suitable for research applications involving the study of the endocannabinoid system and its role in various physiological processes. -
Drug Derivative
N-Acetyl-3,4-MDMC is a drug derivative structurally related to 3,4-methylenedioxymethcathinone. This compound has been investigated for its psychoactive properties and potential interactions with monoamine transporters, particularly serotonin and dopamine receptors. Research applications include studies on its effects on neural activity and behavioral responses in various models of neurotransmission. -
Active Molecule
WAY-604603 is an active molecule that functions primarily as an allosteric modulator of the cannabinoid receptor 1 (CB1). It has demonstrated potential in influencing appetite regulation and neuroprotection. This compound is utilized in research exploring the endocannabinoid system and its implications in metabolic disorders and CNS functions. -
Phytocannabinoids Derivative
Cannabigerol monomethyl ether is a monomethyl ether derivative of the phytocannabinoid, cannabigerol. It exhibits potential biological activity by modulating cannabinoid receptors, thereby influencing a variety of physiological processes. This compound is suitable for research applications focusing on the endocannabinoid system, pharmacological studies of cannabinoids, and elucidation of their therapeutic effects. -
5-HT Derivative
5-Propargyltryptamide (5-PT) is an alkyne-functionalized derivative of serotonin (5-HT), serving as a substrate for serotonylation in living cells. This reagent enables the conjugation of biotin, facilitating the identification of serotonylated proteins through copper-catalyzed click chemistry and mass spectrometry. 5-PT selectively labels and isolates serotonylated proteins in alveolar epithelial cells, making it a valuable tool for proteomic analysis in the study of bronchopulmonary dysplasia and related respiratory conditions. -
Drug Derivative
Indanazoline is a drug derivative that acts primarily as a selective vasoconstrictor. It exhibits significant vasoconstrictive activity through its interactions with adrenergic receptors, making it valuable in cardiovascular research. This compound can be utilized in studies focusing on blood pressure regulation and vascular dynamics, contributing to the understanding of hypertensive conditions and related pharmacological treatments. -
Adrenaline Impurity
Methoxy adrenaline hydrochloride is a synthetic analog of adrenaline, serving as a known impurity in adrenaline formulations. Its presence is critical for quality control in pharmaceutical research, allowing for the assessment of purity and stability in adrenaline products. This compound can also be utilized in various biological studies to investigate adrenergic receptor interactions and signaling pathways. -
Drug Impurity
Metoprolol Impurity 13 is a chemical impurity associated with Metoprolol, a selective beta-1 adrenergic receptor antagonist. This impurity can be utilized for analytical purposes in drug development, including stability studies and quality control assessments. Researchers can employ this compound to ensure the purity and compliance of Metoprolol formulations in pharmaceutical applications. -
Drug Impurity
Ropinirole impurity 5 is a chemical impurity associated with Ropinirole, a dopamine agonist primarily targeting the D2 and D3 dopamine receptors. This impurity is important for analytical and quality control purposes in pharmaceutical research and development. Its identification and quantification are crucial for ensuring the purity and safety of Ropinirole formulations. -
Drug Impurity
Ropinirole impurity 1 is a structural impurity derived from Ropinirole, a selective dopamine agonist primarily targeting D2 dopamine receptors. This reagent is crucial for analytical and quality control applications, serving as a reference standard for assessing the purity and quality of Ropinirole formulations. Its characterization aids in the understanding of processing variability and ensures compliance with regulatory standards in pharmaceutical development. -
Drug Intermediate Control
(Rac)-7-Methoxy propranolol is a key synthetic intermediate that plays a critical role in the production of pharmaceuticals. This compound is utilized in drug formulation and development, particularly in studies related to beta-adrenergic receptor antagonism, which is important for cardiovascular research. Its chemical structure facilitates various synthetic pathways in the creation of effective therapeutics. -
Drug Impurity
Tamsulosin impurity 5 is a known impurity associated with Tamsulosin, a selective alpha-1 adrenergic receptor antagonist primarily used to treat benign prostatic hyperplasia. This specific impurity plays a crucial role in quality control and analytical studies aimed at evaluating the purity and stability of Tamsulosin formulations. It is essential for researchers focusing on the pharmacokinetics and safety profiles of the drug. -
Drug Impurity
Mirabegron impurity 12 is a known impurity associated with the pharmaceutical compound Mirabegron, which primarily acts as a β3-adrenergic receptor agonist. This impurity may be important for analytical characterization and quality control in pharmaceutical research and development. Its detection and quantification can aid in understanding the safety and efficacy profiles of Mirabegron formulations. -
Drug Impurity
Brimonidine impurity 3 is a chemical impurity associated with the drug Brimonidine, primarily targeting adrenergic receptors. This compound is relevant for quality control in pharmaceutical formulations and can be utilized to study the stability and degradation pathways of Brimonidine. Its characterization contributes to the development of safer and more effective drug products. -
Drug Impurity
Carvedilol impurity 13 is a known impurity of the beta-blocker carvedilol, which primarily targets beta-adrenergic receptors. This compound is utilized in pharmaceutical research to assess the purity and stability of carvedilol formulations. Its characterization is essential for ensuring compliance with regulatory standards and improving drug quality. -
Intermediate
2-Benzylaniline is an intermediate compound that serves as a precursor in the synthesis of Compound 15. This derivative exhibits affinity for the D3 dopamine receptor, with a Ki value of 4654 nM. 2-Benzylaniline is valuable in research related to mental disorders, enabling the exploration of therapeutic targets within neuropharmacology.
